Hetero Plasma Sciences Profile
Key Indicators
- Authorised Capital ₹ 41.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 10.01 Cr
as on 07-12-2024
- Company Age 1 Year 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 73.00 Cr
as on 07-12-2024
About Hetero Plasma Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 41.00 Cr and a paid-up capital of Rs 10.01 Cr.
The company currently has active open charges totaling ₹73.00 Cr.
The Key Managerial Personnel (KMP) at Hetero Plasma Sciences Private Limited India are Janardhan Katersala as COMPANY SECRETARY and Divyanshu Patidar as Cfo. Bhaskarreddy Pabbatireddy and Bhavesh Pujara serve as directors at the Company.
- CIN/LLPIN
U46497TS2023PTC175917
- Company No.
175917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2023
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hetero Plasma Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Janardhan Katersala | Company Secretary | 08-Feb-2024 | Current |
| Divyanshu Patidar | CFO | 20-Mar-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskarreddy Pabbatireddy  | Director | 01-Mar-2024 | Current |
| Bhavesh Pujara | Director | 10-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Hetero Plasma Sciences.
Enhance accessibility to Hetero Plasma Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Hetero Plasma Sciences?
Unlock access to Hetero Plasma Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hetero Biopharma LimitedActive 8 years 3 monthsJanardhan Katersala, Divyanshu Patidar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2024 | ₹73.00 Cr | Open |
How Many Employees Work at Hetero Plasma Sciences?
Unlock and access historical data on people associated with Hetero Plasma Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hetero Plasma Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hetero Plasma Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
